Morumbi Resources Completes Shares for Debt Private Placement

TORONTO, ONTARIO--(Marketwired - Sept. 25, 2014) -Morumbi Resources Inc. (TSX VENTURE:MOC) ("Morumbi" or the "Company") is pleased to announce that further to the Company's news release dated August 19, 2014, the Company has completed its shares-for-debt private placement to settle aggregate total debt of $171,403 owing to certain directors, officers, consultants and arm's length parties. Under the debt settlement, the Company issued an aggregate of 3,428,060 common shares (the "Shares") of the Company at a deemed price of $0.05 per Share.

An aggregate of 2,160,000 Shares were issued in settlement of $108,000 of outstanding debt owing to certain directors, employees and consultants of the Company. The Settlement with such directors, employees and consultants constitutes a related party transaction pursuant to Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company was exempt from the formal valuation and minority approval requirements of MI 61-101 in reliance on Sections 5.5(b) and Sections 5.7(b), respectively, of MI 61-101.

All Shares issued under the private placement are subject to a hold period expiring on January 26, 2015.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements regarding, among other things, the Settlements. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, regulatory approval processes. Although Morumbi believes that the assumptions used in preparing the forward-looking information in this news release are reasonable, including that all necessary regulatory approvals will be obtained in a timely manner, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Morumbi disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable securitieslaws.